JAKS Pharma Private Limited(“JAKS”) was founded by Jayant Kumar with aim to transform healthcare through cutting-edge pharmaceutical research, breakthrough treatments, and a commitment to patient well-being. We envision a world where no disease is incurable and every patient can live a healthier and happier life

Our core values serve as the foundation of our company culture and the guiding principles behind everything we do. Patient Centricity, Quality, Integrity, Innovation with Ethics, Global Reach through Innovation and last but not the least the human capital through Employee Development and Compassion. Encompassing all these, we are relentless in our pursuit of groundbreaking solutions. We embrace creative thinking, scientific curiosity, and a pioneering spirit to drive advancements in healthcare.

As we are all aware, patients are at the heart of our mission. Our priority is their needs, safety, and well-being in every decision we make, from research and development to product delivery. We uphold the highest ethical standards i.e. honesty, transparency, and compliance with regulations which are non-negotiable aspects of our identity in all our actions.

Success in healthcare requires a collaborative effort. We actively seek partnerships with like-minded organizations, healthcare professionals, and researchers to accelerate progress.  As a startup, we recognize the importance of adaptability and agility. We are open to change, quick to respond to emerging opportunities, and nimble in our decision-making.

The pharmaceutical industry is witnessing the rise of a new contender, Jaks Pharma, a startup poised to make significant strides in healthcare innovation. Founded by a team of experienced leaders and entrepreneurs, Jaks Pharmaceutical aims to address the pressing needs of patients with a focus on developing cutting-edge treatments for a variety of medical conditions.
With a commitment to excellence and patient care, Jaks Pharma has already begun to make waves in the industry with its novel approach to bringing quality and unique products. The company’s business development is centered around leveraging the latest advancements in medical world and precision medicine to create therapies that are both effective and accessible.
Jaks Pharma’s initial research efforts are directed towards the development of therapies for Dermatological disorders, a market that has seen considerable growth in recent years.
The startup’s vision extends beyond the immediate horizon, with plans to explore treatments in oncology and rare diseases. Jaks Pharma’s long-term goal is to become a leader in personalized medicine, offering tailored treatment options that cater to the individual genetic profiles of patients.
As Jaks Pharma continues to grow, it seeks to establish partnerships with leading healthcare providers and research institutions to expand its reach and impact. The company’s dedication to research and development, combined with its patient-centric approach, positions it as a potential game-changer in the pharmaceutical landscape.